HEM Pharma signs 4.6 billion KRW supply contract for new probiotic product
HEM Pharma has signed a 4.6 billion KRW supply agreement for a new probiotic product with Access Business Group, amounting to roughly 35% of its latest revenue.
How this call is verified
The ▲ Bullish call is auto-verified against the actual KOSPI price in ~13h.
Bar: KOSPI ±0.9% within 24h · every verdict lands on the public ledger
AI comment — why bullish
The newly signed supply contract for a probiotic product, valued at roughly 4.6 billion KRW, could lift HEM파마’s revenue by over a third, providing a near‑term earnings boost. The agreement is with Access Business Group, a health‑food and consumer‑goods manufacturer, and covers both domestic and overseas markets, expanding HEM파마’s distribution footprint. At 4.6 billion KRW, the deal represents 35.63% of the company's most recent revenue, a scale that is material for a KOSDAQ‑listed firm. Assuming the product achieves expected pricing and margins, the additional sales should improve top‑line growth in the coming quarters. However, the filing does not disclose cost structure or timing, so the actual profit impact remains uncertain. If the contract proceeds without delay, the market may view the news as a catalyst for upward price movement.
Market data
HEM파마 · 376270 · KOSDAQ →Previous-close data, updated T+1 · Source: Financial Services Commission of Korea via data.go.kr
Key takeaway
"HEM Pharma signs 4.6 billion KRW supply contract for new probiotic product" — BullBear's AI rates this story as a bullish (positive) signal for markets, with a market-impact score of 70 out of 100. That score reflects how strongly the story is likely to move Bitcoin, US equities, the dollar, and gold, and near-duplicate coverage of the same event is clustered so only the representative article is scored. Reported by 금융감독원 전자공시(DART) on September 09, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Catch the next bull catalyst
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 44.7%.